Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
3.080
+0.090 (3.01%)
At close: Oct 23, 2026, 4:00 PM EDT
3.098
+0.018 (0.58%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Lexaria Bioscience Employees
Lexaria Bioscience had 7 employees as of August 31, 2025. The number of employees did not change compared to the previous year. That makes Lexaria Bioscience the 41,183rd largest employer in the world and 6,282nd in the United States.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$27,714
Profits / Employee
-$1,104,575
Market Cap
5.09M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Aug 31, 2025 | 7 | 0 | - |
| Aug 31, 2024 | 7 | 2 | 40.00% |
| Aug 31, 2023 | 5 | -2 | -28.57% |
| Aug 31, 2022 | 7 | 1 | 16.67% |
| Aug 31, 2021 | 6 | 2 | 50.00% |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Longeveron | 38 |
| AIM ImmunoTech | 21 |
| Cardio Diagnostics Holdings | 17 |
| NeuroSense Therapeutics | 17 |
| Traws Pharma | 7 |
| Alzamend Neuro | 6 |
| Creative Medical Technology Holdings | 4 |
LEXX News
- 3 days ago - Lexaria Bioscience reaches full enrollment in GLP-1-H26-7 study - TheFly
- 3 days ago - Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule - TheNewswire
- 9 days ago - Lexaria Bioscience announces results from animal study GLP-1-A26-1 - TheFly
- 9 days ago - Lexaria Announces Results from Animal Study GLP-1-A26-1 - Accesswire
- 9 days ago - Lexaria Announces Results From Animal Study GLP-1-A26-1 - TheNewswire
- 18 days ago - GLP-1 Weight-Loss/Diabetes Industries Continue Transition to Oral Medications - Accesswire
- 22 days ago - Lexaria Bioscience Registration statement: Registration filing - Filings
- 22 days ago - Lexaria Bioscience files to sell 923,827 shares of common stock for holders - TheFly